Cargando…
BSCI-26. COMPARATIVE METHYLATION PROFILING OF EGFR MUTANT LUNG ADENOCARCINOMA AND PAIRED BRAIN METASTASIS
BACKGROUND: Adenocarcinomas (ADC) are the most common lung tumours and EGFR-mutant lesions have a higher risk of brain metastasis development, which confers poorer survival. Genetic and epigenetic signatures of brain metastasis have not been comprehensively identified. The aim of this study is to co...
Autores principales: | Mamatjan, Yasin, Zuccato, Jeffrey, Karimi, Shirin, Cabanero, Michael, Weiss, Jessica, Sorotsky, Hadas, Tsao, Ming, Shepherd, Frances, Aldape, Kenneth, Zadeh, Gelareh |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Oxford University Press
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7213095/ http://dx.doi.org/10.1093/noajnl/vdz014.022 |
Ejemplares similares
-
71. MGMT PROMOTER METHYLATION IS A PROGNOSTIC BIOMARKER IN EGFR MUTANT LUNG ADENOCARCINOMA WITH BRAIN METASTASES
por: Mamatjan, Yasin, et al.
Publicado: (2020) -
OTHR-09. IDENTIFYING EPIGENETIC SIGNATURES IN LUNG ADENOCARCINOMAS THAT PREDICT DEVELOPMENT OF BRAIN METASTASIS
por: Zuccato, Jeffrey, et al.
Publicado: (2019) -
ECOA-8. Lung adenocarcinoma brain metastasis prediction using tumor DNA methylation profiling
por: Zuccato, Jeffrey, et al.
Publicado: (2021) -
The central nervous system tumor methylation classifier changes neuro-oncology practice for challenging brain tumor diagnoses and directly impacts patient care
por: Karimi, Shirin, et al.
Publicado: (2019) -
Programmed death ligand-1 (PD-L1) expression in meningioma; prognostic significance and its association with hypoxia and NFKB2 expression
por: Karimi, Shirin, et al.
Publicado: (2020)